Bolt Biotherapeutics, Inc. financial data

Symbol
BOLT on Nasdaq
Location
900 Chesapeake Drive, Redwood City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 316 % -42.1%
Debt-to-equity 72.3 % +82.1%
Return On Equity -94.4 % -53.7%
Return On Assets -54.8 % -24.6%
Operating Margin -1.31K % -88.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.92M shares -95%
Common Stock, Shares, Outstanding 1.92M shares -95%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.92M shares +0.58%
Weighted Average Number of Shares Outstanding, Diluted 1.92M shares +0.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.17M USD -62.7%
Research and Development Expense 42.5M USD -32.8%
General and Administrative Expense 15.1M USD -31.4%
Operating Income (Loss) -54.7M USD +29.6%
Nonoperating Income (Expense) 3.97M USD -65.4%
Net Income (Loss) Attributable to Parent -50.7M USD +23.4%
Earnings Per Share, Basic 5 USD/shares +59.9%
Earnings Per Share, Diluted 5 USD/shares +59.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.6M USD +54.8%
Cash, Cash Equivalents, and Short-term Investments 48.5M USD -50.3%
Assets, Current 38.3M USD -50%
Property, Plant and Equipment, Net 1.72M USD -57.9%
Operating Lease, Right-of-Use Asset 20.5M USD +16.8%
Other Assets, Noncurrent 222K USD -27.9%
Assets 75.5M USD -39.2%
Accounts Payable, Current 1.85M USD -29.5%
Employee-related Liabilities, Current 3.3M USD +14.1%
Liabilities, Current 12.3M USD -31.2%
Operating Lease, Liability, Noncurrent 21.6M USD +36%
Other Liabilities, Noncurrent 133K USD
Liabilities 36.7M USD -4.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6K USD +86.4%
Retained Earnings (Accumulated Deficit) -447M USD -12.8%
Stockholders' Equity Attributable to Parent 38.8M USD -54.8%
Liabilities and Equity 75.5M USD -39.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.92M shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.4M USD +42.7%
Operating Lease, Liability 24.2M USD +28%
Depreciation 300K USD -90.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -50.7M USD +23.2%
Lessee, Operating Lease, Liability, to be Paid 34.2M USD +25.8%
Property, Plant and Equipment, Gross 8.56M USD -20.4%
Operating Lease, Liability, Current 2.56M USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.58M USD +60.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.4M USD +24.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +8.93%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.97M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.78M USD +60.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.97M USD +60.4%
Share-based Payment Arrangement, Expense 3.61M USD -62.1%